 | FRI, FEB 14, 2020 | | | | Google Health grows its team | The new coronavirus gets a name | | | | Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.
The World Health Organization has named the new coronavirus that emerged over a month ago: COVID-19, short for Corona Virus Disease.
COVID-19 cases spiked to more than 60,000 this week after Chinese authorities changed how they count confirmed infections. And now the White House is saying it does not have confidence in China's data, according to one official. We'll have more on the virus below.
We've also got news on Google Health and an update on Teva's turnaround.
There's a lot this week in health care and pharma news. Keep submitting your thoughts if there's something you're curious about to CNBC Health Editor Dawn Kopecki at dawn.kopecki@nbcuni.com.
| | Gilead's full steam ahead on coronavirus drug, but China raises IP questions | Gilead's experimental antiviral drug remdesivir began clinical trials in patients with COVID-19 in China this week, just as news emerged that a Chinese drugmaker was ramping up its own manufacturing of the medicine. This is further increasing questions about intellectual property protections after a Chinese institute also filed for a patent on the drug in China. But Gilead says its focus now is on figuring out whether the drug works and ramping up its own manufacturing capacity in case it does. The WHO this week, after a two-day meeting to set research priorities for COVID-19, said we may have answers on how well some antiviral drugs work within a few weeks.
-Meg Tirrell | | | | The virus appears to be sparing one group of people: Kids | COVID-19 has already killed more people than the 2003 SARS epidemic, but it appears to be sparing one population group: kids. WHO officials say the majority infected with the flu-like virus are over 40 years old and it's hitting those with underlying health conditions and the elderly particularly hard. Some infectious disease specialists say older adults may be more vulnerable to the virus due to their weaker immune systems. The apparent lack of children among confirmed cases could also be because they are getting infected but developing milder symptoms and just aren't being reported to local authorities, one expert told me.
-Berkeley Lovelace Jr. | | | | Google Health has grown to more than 500 employees | Google Health has ballooned to more than 500 workers, sources told CNBC, citing an internal directory. That includes new hires — the company has more than a dozen open roles — and employees drawn from other parts of the organization. The new leader, David Feinberg, who's on close terms with the company's CEO, Sundar Pichai, has amassed talent from different teams spanning Deep Mind's health arm in the U.K. and Medical Brain, a project within the machine learning group Google Brain. The unified strategy seems to be about improving health-care search, both within enterprises and for consumers.
-Chrissy Farr | | | | Cruise ship is hardest-hit area by virus outside of China | Nearly 100 more cases of COVID-19 were confirmed this week aboard the Diamond Princess ship. The 2,666 passengers and 1,045 crew members on the cruise ship, which is operated by Carnival's Princess Cruises, have been quarantined in the port of Yokohama since it arrived on Feb. 3. The new cases make it the most concentrated cluster of cases in the world outside of China. So far, 218 people have tested positive on the ship and just 713 have been tested, according to Japanese health officials. Japan is now allowing the most vulnerable guests aboard the ship to disembark and complete their isolation on land, the company said Thursday. "Everything within our power within the ship and the shore is being done to bring this trying time to an end," Capt. Gennaro Arma told passengers. "We only have six days to go."
-Will Feuer | | | | Teva's turnaround: CEO says it's time for growth | When Kare Schultz took the helm at Israeli generic drug giant Teva in November 2017, the company was in need of a turnaround: It had $34 billion in debt, was facing intense pricing pressure in the U.S. and was ensnared in a massive antitrust suit alleging price fixing among generic-drug makers. Since then he's shuttered almost two dozen facilities and laid off 13,000 employees – and now he says the company is positioned for growth. The stock market has agreed, at least in the last 6 months. But the company still faces thousands of lawsuits over its alleged role in the nation's opioid crisis, and the price-fixing suits haven't gone away.
-Meg Tirrell | | Healthy Returns: Investing in health care innovation
How innovators and investors are working with patients and providers to develop dynamic new solutions and create healthy returns.
CNBC presents a one-day event that brings together top health care investors, CEOs and technologists to explore the innovations that will drive better outcomes, financially and clinically.
Led by CNBC's anchors and reporters, Healthy Returns hones in on groundbreaking ideas that will transform the health care industry, cutting through the noise and weeding out the "sales pitch." | | Healthy Returns May 12, 2020
New York | |
♯⊗⋮ 2020 Noticias del Gran Mundo PelÃcula Completa En LÃnea released 2020. story: Cinco años después del fin de la Guerra Civil estadounid...
Post a Comment